Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110378 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Juan Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, School of Food and Biological Engineering, Hefei…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND & AIMS: Ulcerative colitis (UC) is a main type of inflammatory bowel diseases which spreads globally during the westernization of lifestyle over the past few decades. However, the cause of UC is still not fully understood. We aimed to disclose the role of Nogo-B in the development of UC. METHODS: Nogo-deficiency (Nogo-/-) and wild-type male mice were treated with dextran sodium sulfate (DSS) to conduct a UC model, followed by determination of colon and serum inflammatory cytokines level. RAW264.7, THP1 and NCM460 cells were used to determine macrophage inflammation as well as proliferation and migration of NCM460 cells under Nogo-B or miR-155 intervention. RESULTS: Nogo deficiency significantly reduced DSS-induced weight loss, colon length and weight reduction, and inflammatory cells accumulation in the intestinal villus, while increased the expression of tight junctions (TJs) proteins (Zonula occludens-1, Occludin) and adherent junctions (AJs) proteins (E-cadherin, α-catenin), implying that Nogo deficiency attenuated DSS-induced UC. Mechanistically, Nogo-B deficiency reduced TNFα, IL-1β and IL-6 levels in the colon, serum, RAW264.7 cells and THP1-derived macrophages. Furthermore, we identified that Nogo-B inhibition can reduce the maturation of miR-155, which is essential for Nogo-B-affected inflammatory cytokines expression. Interestingly, we determined that Nogo-B and p68 can interact with each other to promote the expression and activation of Nogo-B and p68, thus facilitating miR-155 maturation to induce macrophage inflammation. Blocking p68 inhibited Nogo-B, miR-155, TNFα, IL-1β and IL-6 expression. Moreover, the culture medium collected from Nogo-B overexpressed macrophages can inhibit enterocytes NCM460 cells proliferation and migration. CONCLUSION: We disclose that Nogo deficiency reduced DSS-induced UC via inhibiting p68-miR-155-activated inflammation. Our results indicate that Nogo-B inhibition serves as a new potential therapeutic candidate for the prevention and treatment of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, School of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
- Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- College of Life Sciences, Key Laboratory of Bioactive Materials of Ministry of Education, Nankai University, Tianjin, China.
- Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, School of Food and Biological Engineering, Hefei University of Technology, Hefei, China. Electronic address: chenyuanl…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zheng, J., Wang, S., Zhang, T., Li, H., Zhu, M., Wei, X., Ge, Y., Yang, X., Zhang, S., Xu, H., Duan, Y., Liu, L., & Chen, Y. (2023). Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110378
Vancouver
Zheng J, Wang S, Zhang T, Li H, Zhu M, Wei X, et al. Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110378
BibTeX
@article{Zheng2023,
author = {Zheng, Juan and Wang, Shengnan and Zhang, Tingting and Li, Huaxin and Zhu, Mengmeng and Wei, Xiaoning and Ge, Yu and Yang, Xiaoxiao and Zhang, Shuang and Xu, Hongmei and Duan, Yajun and Liu, Lipei and Chen, Yuanli},
title = {Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110378}
}
EUVIMED